REGN
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
Review Regeneron Pharmaceuticals, Inc. (REGN) earnings with server-rendered company data, supporting context and links to related investor research.
- Annual EPS
- 41.48
- Trailing EPS
- 40.46
- Annual revenue
- $14.34B
- Trailing revenue
- $15.53B
- Next earnings date
- 2026-07-30
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
Regeneron Pharmaceuticals, Inc. (REGN) Earnings research
The REGN earnings page organizes the available earnings-per-share and revenue context for Regeneron Pharmaceuticals, Inc.. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.